Literature DB >> 20420489

Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Siddhartha Mondragón-Rodríguez1, Gustavo Basurto-Islas, Hyoung-gon Lee, George Perry, Xiongwei Zhu, Rudy J Castellani, Mark A Smith.   

Abstract

Amyloid plaques and neurofibrillary tangles are the hallmarks of Alzheimer's disease and have been the focus of disease etiology and pathogenesis. However, in the larger picture of a complex disease, the precise etiology of the lesions per se, as well as the clinical disease, remain to be defined. In this regard, to date no single process has been identified as a useful target and treatment efforts have shown no meaningful progress. Therefore, alternative ideas that may lead to new and effective treatment options are much needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420489      PMCID: PMC2922904          DOI: 10.1586/ern.10.27

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  122 in total

1.  Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease.

Authors:  Ela Kadioglu; Semra Sardas; Selcuk Aslan; Erdal Isik; Ali Esat Karakaya
Journal:  Biomarkers       Date:  2004 Mar-Apr       Impact factor: 2.658

2.  Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

Authors:  X Zhu; R J Castellani; A Takeda; A Nunomura; C S Atwood; G Perry; M A Smith
Journal:  Mech Ageing Dev       Date:  2001-12       Impact factor: 5.432

3.  CSF studies facilitate DNA diagnosis in familial Alzheimer's disease due to a presenilin-1 mutation.

Authors:  Susanne T de Bot; H P H Kremer; Dennis Dooijes; Marcel M Verbeek
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 4.  Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

Authors:  Hyoung-Gon Lee; Rudy J Castellani; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Int J Exp Pathol       Date:  2005-06       Impact factor: 1.925

5.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

6.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

7.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Ad J Vermeij; Patrizia Corrado; Frank Baas; Rosaria Strammiello; Willem A van Gool; John C van Swieten; Annemieke J M Rozemuller
Journal:  Acta Neuropathol       Date:  2009-11-13       Impact factor: 17.088

Review 8.  New age of neuroproteomics in Alzheimer's disease research.

Authors:  Branislav Kovacech; Norbert Zilka; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2009-02-19       Impact factor: 5.046

9.  Differential Expression of Redox Factor-1 Associated with Beta-Amyloid-Mediated Neurotoxicity.

Authors:  Zhiqun Tan; Lei Shi; Steven S Schreiber
Journal:  Open Neurosci J       Date:  2009-01-01

10.  Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta.

Authors:  Kaoru Yamada; Chiori Yabuki; Peter Seubert; Dale Schenk; Yukiko Hori; Sumio Ohtsuki; Tetsuya Terasaki; Tadafumi Hashimoto; Takeshi Iwatsubo
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

View more
  21 in total

1.  Smoking cessation and Alzheimer's disease: facts, fallacies and promise.

Authors:  Janine K Cataldo; Stanton A Glantz
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 2.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

Review 3.  Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-06       Impact factor: 21.566

4.  Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells.

Authors:  Walter J Lukiw; Jian Guo Cui; Li Yuan Yuan; Partha S Bhattacharjee; Madelyn Corkern; Christian Clement; Eli M Kammerman; M J Ball; Yuhai Zhao; Patrick M Sullivan; James M Hill
Journal:  Neuroreport       Date:  2010-10-06       Impact factor: 1.837

Review 5.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

6.  Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/D-galactose Alzheimer's rat model.

Authors:  Weam W Ibrahim; Ahmed S Kamel; Ahmed Wahid; Noha F Abdelkader
Journal:  Inflammopharmacology       Date:  2022-04-01       Impact factor: 4.473

7.  Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.

Authors:  Siddhartha Mondragón-Rodríguez; George Perry; Xiongwei Zhu; Jannic Boehm
Journal:  Int J Alzheimers Dis       Date:  2012-03-08

8.  Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?

Authors:  Siddhartha Mondragón-Rodríguez; George Perry; Xiongwei Zhu; Paula I Moreira; Sylvain Williams
Journal:  Int J Alzheimers Dis       Date:  2012-06-14

9.  Alpha-synuclein repeat variants and survival in Parkinson's disease.

Authors:  Sun Ju Chung; Joanna M Biernacka; Sebastian M Armasu; Kari Anderson; Roberta Frigerio; Jan O Aasly; Grazia Annesi; Anna Rita Bentivoglio; Laura Brighina; Marie-Christine Chartier-Harlin; Stefano Goldwurm; Georgios Hadjigeorgiou; Barbara Jasinska-Myga; Beom Seok Jeon; Yun Joong Kim; Rejko Krüger; Suzanne Lesage; Katerina Markopoulou; George Mellick; Karen E Morrison; Andreas Puschmann; Eng-King Tan; David Crosiers; Jessie Theuns; Christine Van Broeckhoven; Karin Wirdefeldt; Zbigniew K Wszolek; Alexis Elbaz; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2014-02-27       Impact factor: 10.338

10.  Ficus erecta Thunb Leaves Alleviate Memory Loss Induced by Scopolamine in Mice via Regulation of Oxidative Stress and Cholinergic System.

Authors:  Eunjin Sohn; Yu Jin Kim; Joo-Hwan Kim; Soo-Jin Jeong
Journal:  Mol Neurobiol       Date:  2021-04-01       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.